Intercept Blood System for red blood cells: Phase III data

A double-blind, German Phase III trial in 51 cardiovascular surgery patients with acute anemia showed that transfusion of red blood cells treated with Cerus’ Intercept

Read the full 250 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE